LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

LLY

1,008.06

+2%↑

JNJ

242.47

+0.89%↑

ABBV

227.83

-0.92%↓

NVS

162.82

+1.92%↑

AZN

194.72

+0.18%↑

Начало・Списък с акции・MacroGenics Inc

MacroGenics Inc

Затворен

СекторЗдравеопазване

2.36 5.36

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.24

Максимум

2.43

Ключови измерители
By Trading Economics
Приходи	53M 17M
Продажби	51M 73M
Марж на печалбата	23.095
Служители	341
EBITDA	55M 22M

Препоръки
By TipRanks
Препоръки	Неутрален
12-месечна прогноза	+69.49% upside

Дивиденти
By Dow Jones
Следващи печалби	19.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	32M 123M
Предишно отваряне	-3
Предишно затваряне	2.36

Настроения в новините

By Acuity

50%

145 / 351 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

1.47 / 1.64 Подкрепа & съпротива

MacroGenics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.03.2026 г., 18:13 ч. UTC

Придобивния, сливания и поглъщания

Shell to Sell Jiffy Lube to Monomoy in $1.3 Billion Deal -- Update

9.03.2026 г., 17:20 ч. UTC

Значими събития в новините

U.S. Ag Industry Calls for Government Intervention on Fertilizer Prices

9.03.2026 г., 17:15 ч. UTC

Придобивния, сливания и поглъщания

Shell to Sell Jiffy Lube and Premium Velocity to Monomoy for $1.3 Billion

10.03.2026 г., 00:00 ч. UTC

Значими събития в новините

Why Iranian Regime Change Would Transform Global Energy Markets -- WSJ

9.03.2026 г., 23:52 ч. UTC

Пазарно говорене

Gold Steady; May Be Supported by Dollar's Weakness -- Market Talk

9.03.2026 г., 23:50 ч. UTC

Пазарно говорене

Nikkei May Rise as Fears About Higher Energy Prices Ease -- Market Talk

9.03.2026 г., 23:50 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

9.03.2026 г., 23:46 ч. UTC

Пазарно говорене

Значими събития в новините

Correction to Crude Prices Market Talk on March 9

9.03.2026 г., 23:42 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Futures Fall Amid Developments That Could Help Supply -- Market Talk

9.03.2026 г., 23:08 ч. UTC

Значими събития в новините

Front-Month WTI Futures Drop 7.9% to $87.29/bbl, ICE Data Show

9.03.2026 г., 23:07 ч. UTC

Значими събития в новините

Front-Month WTI Futures Fall After Trump Says Iran War Will Be Over 'Very Soon'

9.03.2026 г., 21:29 ч. UTC

Придобивния, сливания и поглъщания

Fortescue Now Fully Owns Peru's Canariaco Copper Project

9.03.2026 г., 21:28 ч. UTC

Придобивния, сливания и поглъщания

Fortescue Completes Acquisition of Remaining Alta Copper Shares

9.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.03.2026 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

9.03.2026 г., 20:47 ч. UTC

Значими събития в новините

The 24 Hours When Oil Markets Went Wild -- WSJ

9.03.2026 г., 20:33 ч. UTC

Значими събития в новините

Stock Market Today: Oil Slips, Stocks Bounce on Trump War-Progress Comments Headline -- WSJ

9.03.2026 г., 20:14 ч. UTC

Пазарно говорене

Значими събития в новините

Oil Moves Lower As Trump Says War Could End Soon -- Market Talk

9.03.2026 г., 19:33 ч. UTC

Значими събития в новините

High Oil Prices Could Crimp Convenience Store Margins -- Barrons.com

9.03.2026 г., 19:17 ч. UTC

Пазарно говорене

Значими събития в новините

Prospect of Added Supply From Oil Reserves Ease Inflation Fears -- Market Talk

9.03.2026 г., 19:14 ч. UTC

Пазарно говорене

Oil Settles Off Highs As G7 Discusses Tapping Reserves -- Market Talk

9.03.2026 г., 19:00 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Settle Lower -- Market Talk

9.03.2026 г., 18:23 ч. UTC

Пазарно говорене

Значими събития в новините

BofA Drops Canada Rate-Cut Call on Higher Oil Prices -- Market Talk

9.03.2026 г., 17:58 ч. UTC

Придобивния, сливания и поглъщания

Shell to Sell Jiffy Lube to Monomoy in $1.3B Deal -- Update

9.03.2026 г., 17:57 ч. UTC

Придобивния, сливания и поглъщания

Activist Investors Target Food Companies as Growth Slows. Lamb Weston Is the Latest. -- Barrons.com

9.03.2026 г., 17:41 ч. UTC

Значими събития в новините

U.S. and Western Allies Turn to Reserves to Counteract Gulf Oil Crisis -- WSJ

9.03.2026 г., 17:41 ч. UTC

Пазарно говорене

Значими събития в новините

Reports of Saudi Production Shut-Ins Keep Bid in Crude -- Market Talk

9.03.2026 г., 17:08 ч. UTC

Пазарно говорене

Canada Rate Outlook Shifts From Long Pause to Late 2026 Hike -- Market Talk

9.03.2026 г., 17:04 ч. UTC

Пазарно говорене

Значими събития в новините

Global Forex and Fixed Income Roundup: Market Talk

9.03.2026 г., 17:04 ч. UTC

Пазарно говорене

Значими събития в новините

Treasury Yields, Dollar Off Highs as G7 Tackles Oil Shock -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

MacroGenics Inc Прогноза

Ценова цел

By TipRanks

69.49% нагоре

12-месечна прогноза

Среден 4 USD 69.49%

Висок 4 USD

Нисък 4 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за MacroGenics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Неутрален

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на MacroGenics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

1.47 / 1.64Подкрепа & съпротива

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bearish.

Настроение

By Acuity

145 / 351 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно MacroGenics Inc

MacroGenics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 × CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, it develops Lorigerlimab, a monoclonal antibody that targets the immune checkpoints PD-1 and cytotoxic T-lymphocyte-associated protein 4; Tebotelimab, an investigational tetravalent DART molecule for PD-1 and lymphocyte-activation gene 3; Retifanlimab, a humanized monoclonal antibody targeting programmed death receptor-1; and IMGC936, an ADC that targets ADAM9, a cell surface protein over-expressed in various solid tumor types. Further, the company develops MGD014 and MGD020, a DART molecule to target the envelope protein of human immunodeficiency virus infected cells and CD3 on T cells; Teplizumab for the treatment of type 1 diabetes; and PRV-3279, a CD32B × CD79B DART molecule for the treatment of autoimmune indications. It has collaborations with Incyte Corporation; Zai Lab Limited; I-Mab Biopharma; and Janssen Biotech, Inc. The company was incorporated in 2000 and is headquartered in Rockville, Maryland.